Susan A. Heilman

410 citations
6 papers · 304 indexed · h-index 6
Topics
Acute Myeloid Leukemia Research (3 papers)Cancer-related Molecular Pathways (3 papers)Cervical Cancer and HPV Research (3 papers)

In The Last Decade

Susan A. Heilman

6 papers receiving 299 citations

Peers

Susan A. Heilman
Comparison fields: 5 of 35
  • Molecular Biology 203
  • Hematology 138
  • Oncology 94
  • Epidemiology 57
  • Genetics 38
Replace Nirmalee Abayasekara with:
Nirmalee Abayasekara United States
Paola Rivera-Muñoz France
Manuela Gambella Italy
I‐Jun Lau United Kingdom
Tommaso Perini Italy
Alix Rousseau France
Samuel Gusscott Canada
Y-T Tai United States
Janet D. Rowley United States
Natalina Elliott United States
Susan A. Heilman relative to Nirmalee Abayasekara United States Nirmalee Abayasekara's profile →
Citations per field
00.5×
Nirmalee Abayasekara · 1×
Citations per year

Countries citing papers authored by Susan A. Heilman

Since Specialization
Citations

This map shows the geographic impact of Susan A. Heilman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan A. Heilman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan A. Heilman more than expected).

Fields of papers citing papers by Susan A. Heilman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan A. Heilman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan A. Heilman. The network helps show where Susan A. Heilman may publish in the future.

Co-authorship network of co-authors of Susan A. Heilman

This figure shows the co-authorship network connecting the top 25 collaborators of Susan A. Heilman. A scholar is included among the top collaborators of Susan A. Heilman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan A. Heilman. Susan A. Heilman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
#WorkIndexed citations
1 31
2 22
3 39
4 97
5 12
6 103

About Susan A. Heilman

Susan A. Heilman is a scholar working on Hematology, Pathology and Forensic Medicine and Oncology, having authored 6 papers that have together received 304 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (3 papers), Cancer-related Molecular Pathways (3 papers) and Cervical Cancer and HPV Research (3 papers). The work is most often cited by research in Hematology (138 citations), Oncology (94 citations) and Molecular Biology (203 citations). Susan A. Heilman has collaborated with scholars based in United States, Netherlands and Canada. Frequent co-authors include Lucio H. Castilla, Jason J. Chen, Sean F. Landrette, Paola N. Perrat, Lisa Garrett, Ya‐Huei Kuo, Greenfield Sluder, Michelle M. Le Beau, Scott C. Kogan and Diego Illanes. Their work appears in journals such as Proceedings of the National Academy of Sciences, Cancer Cell and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026